SZYM Related Analyst Ratings
-
Morgan Stanley Assumed Solazyme (SZYM) at Overweight
-
Solazyme (SZYM) Q4 Results Uninspiring but Execution on Track - Goldman
-
Cowen Starts Solazyme (SZYM) at Outperform
-
Jefferies Lifts Target on Solazyme (SZYM) on Q3 'Beat'
-
Raymond James Upgrades Solazyme (SZYM) to Outperform
-
Raymond James Downgrades Solazyme (SZYM) to Market Perform
-
ThinkEquity Starts Solazyme (SZYM) at Buy
-
UPDATE: UBS Starts Solazyme (SZYM) at Buy; Tailored Renewable Oil Leader With $200B+ Market Opportunity
-
Credit Suisse Starts Solazyme (SZYM) at Outperform
-
Piper Jaffray Starts Solazyme (SZYM) at Underweight
-
Canaccord Genuity Reiterates a 'Buy' on Solazyme (SZYM); Encouraged by Management’s Execution
-
Canaccord Genuity Maintains a 'Buy' on Solazyme (SZYM); Q4 preview: Minding the Milestones
-
Canaccord Genuity on CleanTech/Bioresources: The Revolution in Renewable Chemicals
-
Canaccord Genuity Starts Solazyme (SZYM) at Buy; All About The Algae
-
Jefferies Maintains a 'Buy' on Solazyme (SZYM); Step by Step: Unilever JDA Marks Progress
-
Pacific Crest Starts Solazyme (SZYM) at Outperform
-
Lazard Capital Starts Solazyme (SZYM) at Buy
-
Jefferies Starts Solazyme (SZYM) at Buy
-
Morgan Stanley Starts Solazyme (SZYM) at Overweight
-
Goldman Sachs Starts Solazyme (SZYM) at Buy
-
UPDATE - UBS Upgrades Gevo (GEVO) to Buy on Recent Sell-off
-
Raymond James Starts Solazyme (SZYM) at Outperform
Back to SZYM Stock Lookup
